Incannex Healthcare

IXHLNasdaq Australia Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$40.620 M

$3.40 -2.72%

Close of 22 Sept 2026

Revenue

$12.0K

#3624 by revenue

Earnings

-$46.9M

Loss-making

Shares outstanding

11,964,554

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#363Lite StrategyLITS$41.4M
#364Karyopharm TherapeuticsKPTI$41.3M
#365Incannex HealthcareIXHL$40.6M
#366Seres TherapeuticsMCRB$40.4M
#367NanoviricidesNNVC$39.1M

What if Incannex Healthcare were worth as much as…

Open the what-if tool →

Gold $30.2T

$2,526,962

Per share 744,319× higher

Bitcoin $1.74T

$145,567.90

Per share 42,877× higher

Nvidia $5.52T

$461,008.99

Per share 135,791× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Incannex Healthcare are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.